Suicidality
Digital Suicide Prevention: Can Technology Become a Game-changer?
by Arshya Vahabzadeh, MD; Ned Sahin, PhD; and Amir Kalali, MD Dr. Vahabzadeh is Director of Digital Health, Brain Power, in Cambridge, Massachusetts; Instructor in Psychiatry, Harvard Medical School in Cambridge, Massachusetts; and Innovation Officer at Massachusetts General Hospital Psychiatry Academy in Boston, Massachusetts. Dr. Sahin is Chief Science Officer at Brain Power and Associate […]
Managing the Suicidal Patient in a Split-treatment Relationship
by Ann McNary, JD Ms. McNary is a Senior Risk Manager with PRMS, Inc., Arlington, Virginia Innov Clin Neurosci. 2016;13(3–4):42–45. This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by PRMS, Inc. (www.prms.com), a manager […]
The Neuroscience Report—Vol. 9 (June 29, 2015): Suicidality
Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. Volume 9 (June 29, 2015): SUICIDALITY Journal Articles Current Assessment and Classification […]
Use of Ketamine in Acute Cases of Suicidality
by Jae Lee, DO; Puneet Narang, MD; Manasa Enja, MD; and Steven Lippmann, MD Dr. Lee is resident physician at Hennepin-Regions Psychiatry Program, Minneapolis-St. Paul, Minnesota; Dr. Narang is staff physician and ECT psychiatrist, Regions Hospital, Minneapolis-St. Paul, Minnesota; Dr. Enja is observer physician, University of Louisville School of Medicine, Louisville, Kentucky; and Dr. Lippmann is […]
Letter to the Editor: Suicide Attempts Among Men and Women with Partner Violence According to Borderline Personality Status
Innov Clin Neurosci. 2015;12(1–2):10–11.
Editor’s Message and Issue Highlights: November-December 2014
Dear Colleagues: Welcome to the November–December 2014 issue of Innovations in Clinical Neuroscience. We start this issue with the first of what we hope to be a series of drug development guidance papers created by the collaborative efforts of the clinicians, investigators, industry scientists, and other entities involved in drug development who participate in the […]
ECT-induced Mania
by Jae Lee, DO; Laura Arcand; Puneet Narang, MD; and Steven Lippmann, MD Dr. Lee is Resident Physician, Hennepin-Regions Psychiatry Program, Minneapolis-St. Paul, Minneapolis; Ms. Arcand is physician assistant student, Augsburg College, Minneapolis, Minneapolis; Dr. Narang is Staff Physician, ECT Psychiatrist, Regions Hospital, Minneapolis-St. Paul, Minnesota; and Dr. Lippmann is Professor of Psychiatry, University of Louisville […]
Our Current Understanding of Adult ADHD
by Steven D. Targum and Lenard A. Adler Steven D. Targum, MD, is the scientific director at Clintara LLC, the chief medical officer at Methylation Sciences Inc., BrainCells Inc., and Functional Neuromodulation Inc., the chief medical advisor at Prana Biotechnology Ltd., and a consultant in psychiatry at the Massachusetts General Hospital, Boston, Massachusetts. Dr. Adler […]
Supplemental Materials to September-October 2014 Issue
S-STS_Pediatric_Version Appendices_A-F S-STS_Update_Appendices_A-H Chappell et al Pharmaceutical Sponsor Survey Chappell et al Supplemental Tables
Editor’s Message: Special Edition of ICNS Covers Multiple Aspects of Assessment of Suicidal Ideation and Behavior
Dear Colleagues: Every year, over 800,000 people commit suicide worldwide, with over 40,000 of these deaths occurring annually in the United States. There are many more who attempt it.[1,2] A United States Centers for Disease Control and Prevention (CDC) report indicated that nearly 500,000 people in the United States visit a hospital annually for injuries […]
